Inhibitor Therapeutics, Inc.
INTI
$0.09
$0.0117.03%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 515.80K | 1.29M | 2.38M | 2.98M | 3.74M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 71.00K | 85.00K | 71.50K | 87.40K | 92.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 586.80K | 1.38M | 2.45M | 3.06M | 3.83M |
|
|
|||||
| Total Current Assets | 586.80K | 1.38M | 2.45M | 3.06M | 3.83M |
| Net Property, Plant & Equipment | 50.40K | 57.40K | 64.30K | 71.10K | 77.70K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 637.20K | 1.43M | 2.51M | 3.14M | 3.91M |
|
|
|||||
| Total Accounts Payable | 139.10K | 319.80K | 51.50K | 19.60K | 106.20K |
| Total Accrued Expenses | 9.60K | 33.50K | 690.10K | 40.40K | 7.70K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 26.30K | 29.00K | 24.70K | 27.50K | 26.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 174.90K | 382.30K | 766.30K | 87.50K | 140.00K |
|
|
|||||
| Total Current Liabilities | 174.90K | 382.30K | 766.30K | 87.50K | 140.00K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 21.60K | 29.40K | 36.90K | 44.20K | 52.10K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 3.00M | 3.00M | 3.00M | 3.00M | 3.00M |
| Total Liabilities | 3.20M | 3.41M | 3.80M | 3.13M | 3.19M |
|
|
|||||
| Common Stock & APIC | 54.16M | 54.13M | 54.13M | 54.13M | 54.13M |
| Retained Earnings | -56.72M | -56.11M | -55.42M | -54.12M | -53.41M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -2.56M | -1.98M | -1.29M | 3.50K | 715.60K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -2.56M | -1.98M | -1.29M | 3.50K | 715.60K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -2.56M | -1.98M | -1.29M | 3.50K | 715.60K |
|
|
|||||